Lung Cancer Diagnostic Tests Market Report

Global and China Lung Cancer Diagnostic Tests Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 17, 2022
  • PAGES：179
  • REPORT CODE：GMM1473413
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Growing prevalence of oncologic cases, constant technological advancements in diagnostics, and increasing demand for effective screening tests are some of the prime factors spurring demand for screening tools and techniques across the world. Rising awareness and supportive government initiatives are some additional factors anticipated to boost market growth during the forecast period.

    This report elaborates on the current development of the Lung Cancer Diagnostic Tests industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • BioMarker Strategies

    • Agilent

    • Epigenomics AG

    • Quest Diagnostics

    • Emory Healthcare

    • Mayo Clinic

    • HalioDx

    • GlycoZym

    • Biodesix

    • AIT

    • Courtagen Life Sciences Inc

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Immunoassays

    • Flow Cytometry

    • Rapid Tests

    • Molecular Assays

    • Tissue Arrays

    • Circulating Tumor Cells

    • Pharmacodiagnostics

    • Biomarkers

    • Other Diagnostics Methods

    Application:

    • Precision Medicine

    • Personalized Medicine

    • Cancer Monitoring

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Lung Cancer Diagnostic Tests Industry Overview

      • 1.1.1 Lung Cancer Diagnostic Tests Market Scope and Market Segments

      • 1.1.2 Lung Cancer Diagnostic Tests Industry Characteristics

      • 1.1.3 Global and China Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Lung Cancer Diagnostic Tests Production Value and Growth Rate (2017-2028)

    • 1.2 Global Lung Cancer Diagnostic Tests Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Immunoassays

      • 1.2.2 Flow Cytometry

      • 1.2.3 Rapid Tests

      • 1.2.4 Molecular Assays

      • 1.2.5 Tissue Arrays

      • 1.2.6 Circulating Tumor Cells

      • 1.2.7 Pharmacodiagnostics

      • 1.2.8 Biomarkers

      • 1.2.9 Other Diagnostics Methods

    • 1.3 Global Lung Cancer Diagnostic Tests Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Precision Medicine

      • 1.3.2 Personalized Medicine

      • 1.3.3 Cancer Monitoring

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Lung Cancer Diagnostic Tests Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Lung Cancer Diagnostic Tests Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Lung Cancer Diagnostic Tests Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Lung Cancer Diagnostic Tests Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Lung Cancer Diagnostic Tests Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Lung Cancer Diagnostic Tests Industry Porter's Five Forces Model Analysis

      • 2.2.3 Lung Cancer Diagnostic Tests Industry PEST Analysis

    • 2.3 Lung Cancer Diagnostic Tests Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Lung Cancer Diagnostic Tests Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Lung Cancer Diagnostic Tests Industry

    Chapter 3 Global and China Lung Cancer Diagnostic Tests Market, by Manufacturer

    • 3.1 Global and China Lung Cancer Diagnostic Tests Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Lung Cancer Diagnostic Tests Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Lung Cancer Diagnostic Tests Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Lung Cancer Diagnostic Tests Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Lung Cancer Diagnostic Tests Market Top 3 Players

    Chapter 4 Global and China Lung Cancer Diagnostic Tests Market, by Type (2017-2028)

    • 4.1 Lung Cancer Diagnostic Tests Market Trend, by Type

    • 4.2 Global Lung Cancer Diagnostic Tests Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Lung Cancer Diagnostic Tests Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Lung Cancer Diagnostic Tests Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Lung Cancer Diagnostic Tests Price Trend, by Type (2017-2028)

    • 4.3 China Lung Cancer Diagnostic Tests Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Lung Cancer Diagnostic Tests Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Lung Cancer Diagnostic Tests Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Lung Cancer Diagnostic Tests Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Lung Cancer Diagnostic Tests Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Lung Cancer Diagnostic Tests Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Lung Cancer Diagnostic Tests Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Lung Cancer Diagnostic Tests Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Lung Cancer Diagnostic Tests Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Lung Cancer Diagnostic Tests Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Lung Cancer Diagnostic Tests Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Lung Cancer Diagnostic Tests Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Lung Cancer Diagnostic Tests Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Lung Cancer Diagnostic Tests Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Lung Cancer Diagnostic Tests Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Lung Cancer Diagnostic Tests Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Lung Cancer Diagnostic Tests Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Lung Cancer Diagnostic Tests Market Analysis

    • 7.1 North America Lung Cancer Diagnostic Tests Market, by Type

    • 7.2 North America Lung Cancer Diagnostic Tests Market, by Application

    • 7.3 North America Lung Cancer Diagnostic Tests Market Analysis and Forecast, by Country

      • 7.3.1 United States Lung Cancer Diagnostic Tests Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Lung Cancer Diagnostic Tests Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Lung Cancer Diagnostic Tests Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Lung Cancer Diagnostic Tests Market Analysis

    • 8.1 Europe Lung Cancer Diagnostic Tests Market, by Type

    • 8.2 Europe Lung Cancer Diagnostic Tests Market, by Application

    • 8.3 Europe Lung Cancer Diagnostic Tests Market Analysis and Forecast, by Country

      • 8.3.1 Germany Lung Cancer Diagnostic Tests Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Lung Cancer Diagnostic Tests Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Lung Cancer Diagnostic Tests Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Lung Cancer Diagnostic Tests Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Lung Cancer Diagnostic Tests Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Lung Cancer Diagnostic Tests Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Lung Cancer Diagnostic Tests Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Lung Cancer Diagnostic Tests Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Lung Cancer Diagnostic Tests Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Lung Cancer Diagnostic Tests Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Lung Cancer Diagnostic Tests Market Analysis

    • 9.1 APAC Lung Cancer Diagnostic Tests Market, by Type

    • 9.2 APAC Lung Cancer Diagnostic Tests Market, by Application

    • 9.3 APAC Lung Cancer Diagnostic Tests Market Analysis and Forecast, by Country

      • 9.3.1 China Lung Cancer Diagnostic Tests Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Lung Cancer Diagnostic Tests Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Lung Cancer Diagnostic Tests Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Lung Cancer Diagnostic Tests Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Lung Cancer Diagnostic Tests Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Lung Cancer Diagnostic Tests Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Lung Cancer Diagnostic Tests Market Analysis

    • 10.1 Latin America, Middle East and Africa Lung Cancer Diagnostic Tests Market, by Type

    • 10.2 Latin America, Middle East and Africa Lung Cancer Diagnostic Tests Market, by Application

    • 10.3 Latin America, Middle East and Africa Lung Cancer Diagnostic Tests Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Lung Cancer Diagnostic Tests Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Lung Cancer Diagnostic Tests Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Lung Cancer Diagnostic Tests Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Lung Cancer Diagnostic Tests Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Lung Cancer Diagnostic Tests Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Lung Cancer Diagnostic Tests Company Profiles

      • 11.1 BioMarker Strategies

        • 11.1.1 BioMarker Strategies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 BioMarker Strategies Lung Cancer Diagnostic Tests Product Profiles, Application and Specification

        • 11.1.3 BioMarker Strategies Lung Cancer Diagnostic Tests Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Agilent

        • 11.2.1 Agilent Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Agilent Lung Cancer Diagnostic Tests Product Profiles, Application and Specification

        • 11.2.3 Agilent Lung Cancer Diagnostic Tests Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Epigenomics AG

        • 11.3.1 Epigenomics AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Epigenomics AG Lung Cancer Diagnostic Tests Product Profiles, Application and Specification

        • 11.3.3 Epigenomics AG Lung Cancer Diagnostic Tests Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Quest Diagnostics

        • 11.4.1 Quest Diagnostics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Quest Diagnostics Lung Cancer Diagnostic Tests Product Profiles, Application and Specification

        • 11.4.3 Quest Diagnostics Lung Cancer Diagnostic Tests Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Emory Healthcare

        • 11.5.1 Emory Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Emory Healthcare Lung Cancer Diagnostic Tests Product Profiles, Application and Specification

        • 11.5.3 Emory Healthcare Lung Cancer Diagnostic Tests Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Mayo Clinic

        • 11.6.1 Mayo Clinic Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Mayo Clinic Lung Cancer Diagnostic Tests Product Profiles, Application and Specification

        • 11.6.3 Mayo Clinic Lung Cancer Diagnostic Tests Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 HalioDx

        • 11.7.1 HalioDx Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 HalioDx Lung Cancer Diagnostic Tests Product Profiles, Application and Specification

        • 11.7.3 HalioDx Lung Cancer Diagnostic Tests Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 GlycoZym

        • 11.8.1 GlycoZym Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 GlycoZym Lung Cancer Diagnostic Tests Product Profiles, Application and Specification

        • 11.8.3 GlycoZym Lung Cancer Diagnostic Tests Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Biodesix

        • 11.9.1 Biodesix Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Biodesix Lung Cancer Diagnostic Tests Product Profiles, Application and Specification

        • 11.9.3 Biodesix Lung Cancer Diagnostic Tests Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 AIT

        • 11.10.1 AIT Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 AIT Lung Cancer Diagnostic Tests Product Profiles, Application and Specification

        • 11.10.3 AIT Lung Cancer Diagnostic Tests Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Courtagen Life Sciences Inc

        • 11.11.1 Courtagen Life Sciences Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Product Profiles, Application and Specification

        • 11.11.3 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Lung Cancer Diagnostic Tests Industry Investment Prospect and Risk Assessment

    • 12.1 Lung Cancer Diagnostic Tests Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Lung Cancer Diagnostic Tests Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2017-2028)

    • Figure China Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2017-2028)

    • Figure Global Lung Cancer Diagnostic Tests Production Value and Growth Rate (2017-2028)

    • Figure China Lung Cancer Diagnostic Tests Production Value and Growth Rate (2017-2028)

    • Figure Global Lung Cancer Diagnostic Tests Market Size and Growth Rate of Immunoassays (2017-2028)

    • Figure Global Lung Cancer Diagnostic Tests Market Size and Growth Rate of Flow Cytometry (2017-2028)

    • Figure Global Lung Cancer Diagnostic Tests Market Size and Growth Rate of Rapid Tests (2017-2028)

    • Figure Global Lung Cancer Diagnostic Tests Market Size and Growth Rate of Molecular Assays (2017-2028)

    • Figure Global Lung Cancer Diagnostic Tests Market Size and Growth Rate of Tissue Arrays (2017-2028)

    • Figure Global Lung Cancer Diagnostic Tests Market Size and Growth Rate of Circulating Tumor Cells (2017-2028)

    • Figure Global Lung Cancer Diagnostic Tests Market Size and Growth Rate of Pharmacodiagnostics (2017-2028)

    • Figure Global Lung Cancer Diagnostic Tests Market Size and Growth Rate of Biomarkers (2017-2028)

    • Figure Global Lung Cancer Diagnostic Tests Market Size and Growth Rate of Other Diagnostics Methods (2017-2028)

    • Figure Global Lung Cancer Diagnostic Tests Market Size and Growth Rate of Precision Medicine (2017-2028)

    • Figure Global Lung Cancer Diagnostic Tests Market Size and Growth Rate of Personalized Medicine (2017-2028)

    • Figure Global Lung Cancer Diagnostic Tests Market Size and Growth Rate of Cancer Monitoring (2017-2028)

    • Figure North America Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Lung Cancer Diagnostic Tests Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Lung Cancer Diagnostic Tests Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Lung Cancer Diagnostic Tests Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Lung Cancer Diagnostic Tests Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Lung Cancer Diagnostic Tests Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Lung Cancer Diagnostic Tests Market Share, by Manufacturer in 2021

    • Figure Global and China Lung Cancer Diagnostic Tests Market Share, by Manufacturer in 2022

    • Table Global Lung Cancer Diagnostic Tests Sales Volume, by Type (2017-2028)

    • Table Global Lung Cancer Diagnostic Tests Sales Volume Share, by Type (2017-2028)

    • Figure Global Lung Cancer Diagnostic Tests Sales Volume Share, by Type (2017-2028)

    • Table Global Lung Cancer Diagnostic Tests Sales Value, by Type (2017-2028)

    • Table Global Lung Cancer Diagnostic Tests Sales Value Share, by Type (2017-2028)

    • Figure Global Lung Cancer Diagnostic Tests Price Trend, by Type (2017-2028)

    • Table China Lung Cancer Diagnostic Tests Sales Volume, by Type (2017-2028)

    • Table China Lung Cancer Diagnostic Tests Sales Volume Share, by Type (2017-2028)

    • Figure China Lung Cancer Diagnostic Tests Sales Volume Share, by Type (2017-2028)

    • Table China Lung Cancer Diagnostic Tests Sales Value, by Type (2017-2028)

    • Table China Lung Cancer Diagnostic Tests Sales Value Share, by Type (2017-2028)

    • Figure China Lung Cancer Diagnostic Tests Price Trend, by Type (2017-2028)

    • Table Global Lung Cancer Diagnostic Tests Sales Volume, by Application (2017-2028)

    • Table Global Lung Cancer Diagnostic Tests Sales Volume Share, by Application (2017-2028)

    • Figure Global Lung Cancer Diagnostic Tests Sales Volume Share, by Application (2017-2028)

    • Table Global Lung Cancer Diagnostic Tests Sales Value, by Application (2017-2028)

    • Table Global Lung Cancer Diagnostic Tests Sales Value Share, by Application (2017-2028)

    • Figure Global Lung Cancer Diagnostic Tests Sales Value Share, by Application (2017-2028)

    • Table China Lung Cancer Diagnostic Tests Sales Volume, by Application (2017-2028)

    • Table China Lung Cancer Diagnostic Tests Sales Volume Share, by Application (2017-2028)

    • Figure China Lung Cancer Diagnostic Tests Sales Volume Share, by Application (2017-2028)

    • Table China Lung Cancer Diagnostic Tests Sales Value, by Application (2017-2028)

    • Table China Lung Cancer Diagnostic Tests Sales Value Share, by Application (2017-2028)

    • Figure China Lung Cancer Diagnostic Tests Sales Value Share, by Application (2017-2028)

    • Figure China Lung Cancer Diagnostic Tests Production, Import, Consumption and Export (2017-2022)

    • Figure North America Lung Cancer Diagnostic Tests Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Lung Cancer Diagnostic Tests Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Lung Cancer Diagnostic Tests Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Lung Cancer Diagnostic Tests Production, Import, Consumption and Export (2017-2022)

    • Table North America Lung Cancer Diagnostic Tests Sales Volume, by Type (2017-2028)

    • Table North America Lung Cancer Diagnostic Tests Sales Volume Share, by Type (2017-2028)

    • Figure North America Lung Cancer Diagnostic Tests Sales Volume Share, by Type (2017-2028)

    • Table North America Lung Cancer Diagnostic Tests Sales Volume, by Application (2017-2028)

    • Table North America Lung Cancer Diagnostic Tests Sales Volume Share, by Application (2017-2028)

    • Figure North America Lung Cancer Diagnostic Tests Sales Volume Share, by Application (2017-2028)

    • Figure United States Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2017-2028)

    • Figure United States Lung Cancer Diagnostic Tests Sales Value and Growth Rate (2017-2028)

    • Figure Canada Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Lung Cancer Diagnostic Tests Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Lung Cancer Diagnostic Tests Sales Value and Growth Rate (2017-2028)

    • Table Europe Lung Cancer Diagnostic Tests Sales Volume, by Type (2017-2028)

    • Table Europe Lung Cancer Diagnostic Tests Sales Volume Share, by Type (2017-2028)

    • Figure Europe Lung Cancer Diagnostic Tests Sales Volume Share, by Type (2017-2028)

    • Table Europe Lung Cancer Diagnostic Tests Sales Volume, by Application (2017-2028)

    • Table Europe Lung Cancer Diagnostic Tests Sales Volume Share, by Application (2017-2028)

    • Figure Europe Lung Cancer Diagnostic Tests Sales Volume Share, by Application (2017-2028)

    • Figure Germany Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Lung Cancer Diagnostic Tests Sales Value and Growth Rate (2017-2028)

    • Figure UK Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2017-2028)

    • Figure UK Lung Cancer Diagnostic Tests Sales Value and Growth Rate (2017-2028)

    • Figure France Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2017-2028)

    • Figure France Lung Cancer Diagnostic Tests Sales Value and Growth Rate (2017-2028)

    • Figure Italy Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Lung Cancer Diagnostic Tests Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Lung Cancer Diagnostic Tests Sales Value and Growth Rate (2017-2028)

    • Figure Spain Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Lung Cancer Diagnostic Tests Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Lung Cancer Diagnostic Tests Sales Value and Growth Rate (2017-2028)

    • Figure Poland Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Lung Cancer Diagnostic Tests Sales Value and Growth Rate (2017-2028)

    • Figure Russia Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Lung Cancer Diagnostic Tests Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Lung Cancer Diagnostic Tests Sales Value and Growth Rate (2017-2028)

    • Table APAC Lung Cancer Diagnostic Tests Sales Volume, by Type (2017-2028)

    • Table APAC Lung Cancer Diagnostic Tests Sales Volume Share, by Type (2017-2028)

    • Figure APAC Lung Cancer Diagnostic Tests Sales Volume Share, by Type (2017-2028)

    • Table APAC Lung Cancer Diagnostic Tests Sales Volume, by Application (2017-2028)

    • Table APAC Lung Cancer Diagnostic Tests Sales Volume Share, by Application (2017-2028)

    • Figure APAC Lung Cancer Diagnostic Tests Sales Volume Share, by Application (2017-2028)

    • Figure China Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2017-2028)

    • Figure China Lung Cancer Diagnostic Tests Sales Value and Growth Rate (2017-2028)

    • Figure Japan Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Lung Cancer Diagnostic Tests Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Lung Cancer Diagnostic Tests Sales Value and Growth Rate (2017-2028)

    • Figure India Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2017-2028)

    • Figure India Lung Cancer Diagnostic Tests Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Lung Cancer Diagnostic Tests Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Lung Cancer Diagnostic Tests Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Lung Cancer Diagnostic Tests Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Lung Cancer Diagnostic Tests Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Lung Cancer Diagnostic Tests Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Lung Cancer Diagnostic Tests Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Lung Cancer Diagnostic Tests Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Lung Cancer Diagnostic Tests Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Lung Cancer Diagnostic Tests Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Lung Cancer Diagnostic Tests Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Lung Cancer Diagnostic Tests Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Lung Cancer Diagnostic Tests Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Lung Cancer Diagnostic Tests Sales Value and Growth Rate (2017-2028)

    • Table BioMarker Strategies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table BioMarker Strategies Product Profiles, Application and Specification

    • Table BioMarker Strategies Lung Cancer Diagnostic Tests Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Agilent Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Agilent Product Profiles, Application and Specification

    • Table Agilent Lung Cancer Diagnostic Tests Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Epigenomics AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Epigenomics AG Product Profiles, Application and Specification

    • Table Epigenomics AG Lung Cancer Diagnostic Tests Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Quest Diagnostics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Quest Diagnostics Product Profiles, Application and Specification

    • Table Quest Diagnostics Lung Cancer Diagnostic Tests Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Emory Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Emory Healthcare Product Profiles, Application and Specification

    • Table Emory Healthcare Lung Cancer Diagnostic Tests Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Mayo Clinic Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Mayo Clinic Product Profiles, Application and Specification

    • Table Mayo Clinic Lung Cancer Diagnostic Tests Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table HalioDx Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table HalioDx Product Profiles, Application and Specification

    • Table HalioDx Lung Cancer Diagnostic Tests Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlycoZym Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlycoZym Product Profiles, Application and Specification

    • Table GlycoZym Lung Cancer Diagnostic Tests Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Biodesix Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Biodesix Product Profiles, Application and Specification

    • Table Biodesix Lung Cancer Diagnostic Tests Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AIT Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AIT Product Profiles, Application and Specification

    • Table AIT Lung Cancer Diagnostic Tests Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Courtagen Life Sciences Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Courtagen Life Sciences Inc Product Profiles, Application and Specification

    • Table Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US